These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12242599)
1. Effect of gender in the disposition of albendazole metabolites in humans. Mirfazaelian A; Dadashzadeh S; Rouini MR Eur J Clin Pharmacol; 2002 Sep; 58(6):403-8. PubMed ID: 12242599 [TBL] [Abstract][Full Text] [Related]
2. Dose dependent pharmacokinetics of albendazole in human. Mirfazaelian A; Rouini MR; Dadashzadeh S Biopharm Drug Dispos; 2002 Dec; 23(9):379-83. PubMed ID: 12469331 [TBL] [Abstract][Full Text] [Related]
3. Time dependent pharmacokinetics of albendazole in human. Mirfazaelian A; Rouini MR; Dadashzadeh S Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration. Li Z; Chen C; Ai D; Wang C; Li J; Qi Y; Yi W; Shen H; Cao J Environ Toxicol Pharmacol; 2012 Mar; 33(2):197-204. PubMed ID: 22227164 [TBL] [Abstract][Full Text] [Related]
5. Effect of age and gender in the pharmacokinetics of albendazole and albendazole sulphoxide enantiomers in goats. Capece BP; Afonso SM; Lazáro R; Harun M; Godoy C; Castells G; Cristòfol C Res Vet Sci; 2009 Jun; 86(3):498-502. PubMed ID: 18805559 [TBL] [Abstract][Full Text] [Related]
6. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys. Gokbulut C; Akar F; McKellar QA Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142 [TBL] [Abstract][Full Text] [Related]
7. Dose-dependent systemic exposure of albendazole metabolites in lambs. Alvarez L; Suárez G; Ceballos L; Moreno L; Lanusse C J Vet Pharmacol Ther; 2012 Aug; 35(4):365-72. PubMed ID: 21819410 [TBL] [Abstract][Full Text] [Related]
8. Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole. Merino G; Molina AJ; García JL; Pulido MM; Prieto JG; Alvarez AI J Pharm Pharmacol; 2003 Jun; 55(6):757-64. PubMed ID: 12841935 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of albendazole in New Zealand white rabbits: oral versus intraperitoneal administration. Cai ZY; Galettis P; Lu Y; Morris DL; Pourgholami MH Anticancer Res; 2007; 27(1A):417-22. PubMed ID: 17352262 [TBL] [Abstract][Full Text] [Related]
10. Disposition kinetics of albendazole and metabolites in laying hens. Bistoletti M; Alvarez L; Lanusse C; Moreno L J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs. Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144 [TBL] [Abstract][Full Text] [Related]
12. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs. Gokbulut C; Bilgili A; Hanedan B; McKellar QA Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study. Zhao RK; Cheng G; Tang J; Song J; Peng WX Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103 [TBL] [Abstract][Full Text] [Related]
14. Dose dependent pharmacokinetics of naproxen in man. Niazi SK; Alam SM; Ahmad SI Biopharm Drug Dispos; 1996 May; 17(4):355-61. PubMed ID: 8743406 [TBL] [Abstract][Full Text] [Related]
15. Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes. Gokbulut C; Cirak VY; Senlik B Vet Res Commun; 2006 Oct; 30(7):791-805. PubMed ID: 17004041 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of albendazole in children with hydatid disease. Okelo GB; Hagos B; Ng'ang'a JN; Ogeto JO East Afr Med J; 1993 Oct; 70(10):643-5. PubMed ID: 8187662 [TBL] [Abstract][Full Text] [Related]
17. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone. Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286 [TBL] [Abstract][Full Text] [Related]
18. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human. Dadashzadeh S; Javadian B; Sadeghian S Biopharm Drug Dispos; 2006 Oct; 27(7):329-34. PubMed ID: 16892180 [TBL] [Abstract][Full Text] [Related]
19. Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity. Kharasch ED; Hoffer C; Walker A; Sheffels P Clin Pharmacol Ther; 2003 Mar; 73(3):199-208. PubMed ID: 12621385 [TBL] [Abstract][Full Text] [Related]
20. Sex differences in the disposition of albendazole metabolites in sheep. Cristòfol C; Navarro M; Franquelo C; Valladares JE; Arboix M Vet Parasitol; 1998 Aug; 78(3):223-31. PubMed ID: 9760064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]